-
-
Call more information
660-596-2224 -
Authors: Andrew King, MD, MS et al ASA Monitor April 2024, Vol. 88, 33. A family history of deaths under general anesthesia – an unlikely nightmare for the modern anesthesiologist. But for Dr. Jim Villiers, that was a challenge he had to face for his patient in 1960s Melbourne, Australia. Malignant hyperthermia (MH), a topic […]
Read MoreASA Monitor April 2024, Vol. 88, 14. Unique approval for neuromuscular disorder treatment The U.S. Food and Drug Administration (FDA) has granted approval for Takeda’s Gammagard Liquid® as an intravenous immunoglobulin (IVIG) therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a rare immune-mediated neuromuscular disorder, and Gammagard Liquid is now the only IVIG therapy […]
Read MoreAUTHORS: Araujo-Duran, Jorge MD et al Anesthesia & Analgesia 138(4):p 751-759, April 2024. | BACKGROUND: Relaxation and distraction provided by virtual reality presentations might be analgesic and reduce the need for opioid analgesia. We tested the hypothesis that a virtual reality program (AppliedVR) decreases acute postoperative pain and opioid requirements in patients recovering from hip arthroplasty. We […]
Read MoreAuthor: Dave Muoio Fierce Healthcare A Michigan jury has found Detroit-based Henry Ford Health and some of its practitioners to be negligent in a case involving a delayed caesarean section and resulting severe disability. Jurors handed down the verdict March 28 and awarded $120 million in damages to a mother, Kristen Drake, and her 13-year-old […]
Read MoreASA Monitor April 2024, Vol. 88, 29. Worldwide, over 25% (15 million) of deaths are due to the two leading causes of mortality – heart disease and stroke (Lancet 2019;393:401). The third-leading cause of death in the United States and the world is 30-day postoperative mortality, with 7.7% of all global deaths (4.2 million people) (Lancet 2019;393:401). Postoperative […]
Read More